August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
TOP Biotechs at ASCO: Kate Dilligan on Scalp Cooling Innovation and Insurance Access
Jun 23, 2025, 07:16

TOP Biotechs at ASCO: Kate Dilligan on Scalp Cooling Innovation and Insurance Access

In this episode of TOP Biotechs at ASCO, Kate Diligan, Founder and CEO of Cooler Heads Care, shares how the company is making scalp cooling more affordable, accessible, and clinically validated for cancer patients undergoing chemotherapy.

  • Cooler Heads offers the only U.S.-based, FDA-cleared portable scalp cooling system, enabling infusion centers to provide effective scalp cooling profitably.
  • Scalp cooling helps patients with solid tumors reduce chemotherapy-induced alopecia, supporting privacy and quality of life—far beyond cosmetic benefits.
  • New clinical data shows significant improvements in patient outcomes and emotional well-being with scalp cooling.
  • A key regulatory milestone: Starting January 2026, Medicare will reclassify scalp cooling from Category 3 to Category 1 codes, paving the way for broad insurance reimbursement.
  • Cooler Heads is actively working with partners to address financial toxicity and expand access to scalp cooling for all eligible patients.

A compelling look at how patient-centered innovation can transform cancer care.